|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Tumor suppression, p53 and retrotransposons
|
1R01CA222579-01
|
$370,575
|
|
ABRAMS, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-04
|
$401,456
|
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
|
1K22CA222669-01
|
$182,485
|
|
ADEEGBE, OLAKUNLE
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-04
|
$659,886
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-05
|
$355,993
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
|
5R00CA194309-04
|
$210,465
|
|
AIRD, KATHERINE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
|
5R01CA204639-03
|
$698,696
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-23
|
$289,175
|
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
|
5R01CA182872-05
|
$661,842
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
|
5R01CA214018-02
|
$481,065
|
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
|
5R01CA211080-02
|
$530,585
|
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048339-25
|
$68,181
|
|
ARANETA, MARIA ROSARIO
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-03
|
$490,809
|
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Personalized vaccine for patients with AML
|
5R01CA212649-02
|
$721,179
|
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Radiolabeled FASN Inhibitors for PET Imaging
|
5R21CA213157-02
|
$176,883
|
|
BABICH, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
5R01CA183101-04
|
$620,486
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
DNA damage signaling to immune checkpoints
|
5R01CA204173-02
|
$376,715
|
|
BAKKENIST, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-05
|
$379,725
|
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-03
|
$848,325
|
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Systems genetics analysis of tumor evolution in the mouse
|
5R35CA210018-02
|
$951,000
|
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Catch and Release Immunotoxins: CAR-Bombs for Cancer
|
5R01CA204192-02
|
$360,914
|
|
BALTHASAR, JOSEPH
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Contribution of development and age to breast cancer etiology
|
5R01CA190980-04
|
$569,421
|
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
An automated high-throughput tissue model for screening metastatic effectors
|
5R01CA186134-04
|
$625,580
|
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
5R01CA193219-04
|
$361,425
|
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment
|
5R03CA212924-02
|
$82,500
|
|
BENEDICT, CATHERINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Role of KDM5A in pRB-mediated differentiation
|
5R01CA211095-02
|
$372,740
|
|
BENEVOLENSKAYA, ELIZAVETA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
|
5R00CA197762-04
|
$249,000
|
|
BERGER, ALICE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biochemical Analyses of Type II DNA Topoisomerases
|
5R01CA077373-21
|
$445,382
|
|
BERGER, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
|
Epigenetic regulation by tumor suppressor p53
|
5R01CA078831-19
|
$352,848
|
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
|
5R01CA204894-02
|
$402,600
|
|
BIELAS, JASON
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metabolic liabilities of cancer cells to the tumor nutrient environment
|
5K22CA193660-03
|
$130,032
|
|
BIRSOY, KIVANC
|
ROCKEFELLER UNIVERSITY
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
5F30CA214009-02
|
$49,524
|
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
|
5R00CA194318-04
|
$249,001
|
|
BITLER, BENJAMIN
|
UNIVERSITY OF COLORADO DENVER
|
|
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
|
5R01CA211052-02
|
$362,569
|
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Hsp90B in Bladder Cancer
|
1R01CA222894-01
|
$365,328
|
|
BLAGG, BRIAN
|
UNIVERSITY OF NOTRE DAME
|
|
Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls
|
5R44CA213476-02
|
$751,890
|
|
BOGEN, STEVEN
|
MEDICAL DISCOVERY PARTNERS, LLC
|
|
Chemical probes for specific targeting of matrix metallo proteases
|
5R01CA179253-05
|
$333,038
|
|
BOGYO, MATTHEW
|
STANFORD UNIVERSITY
|
|
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer
|
5R01CA183921-04
|
$548,628
|
|
BOOHAKER, REBECCA
|
SOUTHERN RESEARCH INSTITUTE
|
|
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
|
5R01CA213149-02
|
$475,541
|
|
BOPPART, STEPHEN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
|
5F30CA206255-02
|
$34,447
|
|
BORCHERDING, NICHOLAS
|
UNIVERSITY OF IOWA
|
|
Dissection of eIF4E dependent mRNA export
|
5R01CA080728-18
|
$210,799
|
|
BORDEN, KATHERINE
|
UNIVERSITY OF MONTREAL
|
|
Regulatory T Cell Control of Intestinal Tumorigenesis
|
5R01CA168670-05
|
$345,488
|
|
BOTHWELL, ALFRED
|
YALE UNIVERSITY
|
|
Experimental study of stress and DNA damage in humans: Mediators and moderators
|
5R01CA211371-02
|
$420,080
|
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Leukocyte telomere length in bladder cancer survivors: Diet and exercise trial
|
5R21CA212628-02
|
$203,580
|
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Total relevant funding to Arctic for this search: $1,293,570
|